RTSL Projected Dividend Yield
Rapid Therapeutic Science Laboratories Inc ( OTCBB : RTSL )Rapid Therapeutic Science Laboratories operates as a biotech company focusing on aerosol delivery of cannabinoids to the systemic blood stream though the pulmonary route of administration. Co. manufactures white label products as well as its own branded metered dose inhalers under the Rxoid name using proprietary blends of pure cannabinoids such as cannabidiol and/or cannabigerol. Co. is also testing cannabinol blends and psilocybin where it is legal. Co. uses no tetrahydrocannabinol (THC) in its main products. However, Co. does provide consulting for formulation of THC products in legal jurisdictions, although it has no direct ownership in any THC companies or products. 20 YEAR PERFORMANCE RESULTS |
RTSL Dividend History Detail RTSL Dividend News RTSL Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |